Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.

One hundred and ninety-one adults with acute myelogenous leukaemia were treated with combination chemotherapy consisting of daunorubicin and cytosine arabinoside (Barts III). Sixty-three patients achieved remission and were admitted to one of 3 trials of active immunotherapy: immunotherapy alone, im...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, R., Zuhrie, S. R., Freeman, C. B., Taylor, G. M., MacIver, J. E., Geary, C. G., Delamore, I. W., Hull, P. J., Tooth, J. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1978
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009578/
https://www.ncbi.nlm.nih.gov/pubmed/272913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009578/
https://www.ncbi.nlm.nih.gov/pubmed/272913

Ejemplares similares